SNC
AMGN icon

Stifel Nicolaus & Co’s Amgen AMGN Stock Holding History

Stifel Nicolaus & Co’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$6.49M Buy
58,011
+3,270
+6% +$355K 0.11% 194
2013
Q2 		$5.4M Buy
+54,741
New +$5.68M 0.1% 193

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Stifel Nicolaus & Co's AMGN Position: Q3 2013 in Review

Stifel Nicolaus & Co increased its Amgen (AMGN) stake by 6% in Q3 2013, buying an estimated $355K and bringing the position to 58,011 shares worth $6.49M. The position accounts for 0.11% of the portfolio, ranked #194.

Stifel Nicolaus & Co first reported a position in AMGN in Q2 2013 and has held it in 2 quarters since. 1,062 funds tracked by Wall St. Rank hold AMGN as of Q3 2013.

  • Stifel Nicolaus & Co held 58,011 shares of Amgen worth $6.49M as of Q3 2013.
  • Stifel Nicolaus & Co bought 3,270 Amgen shares in Q3 2013, an estimated $355K.
  • Amgen made up 0.11% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #194 holding.
  • Stifel Nicolaus & Co first reported a position in Amgen in Q2 2013 and has held it in 2 quarters since.
  • 1,062 funds tracked by Wall St. Rank held Amgen as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.